Allopurinol mouth rinse for prophylaxis of fluorouracil-induced mucositis

European Journal of Cancer Care

Volumn 19, Issue 3, 2010, Pages 308-312

  Panahi, Y ^a   Ala, S ^b   Saeedi, M ^b   Okhovatian, A ^b   Bazzaz, N ^a   Naghizadeh, M M ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Allopurinol; Chemotherapy; Fluorouracil induced mucositis; Prophylaxis

Indexed keywords

ALLOPURINOL; ANTINEOPLASTIC ANTIMETABOLITE; FLUOROURACIL; MOUTHWASH;

ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MIDDLE AGED; NEOPLASM; RANDOMIZED CONTROLLED TRIAL; STOMATITIS;

ADULT; ALLOPURINOL; ANTIMETABOLITES, ANTINEOPLASTIC; DOUBLE-BLIND METHOD; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MOUTHWASHES; NEOPLASMS; STOMATITIS;

EID: 77953171519     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2008.01042.x     Document Type: Article

References (16)

1. Clark PI, Slevin ML. Allopurinol mouthwashes and 5-fluorouracil induced oral toxicity. European Journal of Surgical Oncology 1985, 11:267-268.
2. Cruz LB, Ribeiro AS, Rech A, Rosa LG, Castro CG, Brunetto AL. Influence of low-energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy. Pediatr Blood Cancer 2007, 48:435-440.
3. Epstein JB, Tsang AH, Warkentin D, Ship JA. The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis: a review of the literature. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 2002, 94:39-44.
4. Faure M, Lissi EA, Videla LA. Antioxidant capacity of allopurinol in biological systems. Biochemistry International 1990, 21:357-366.
5. Howell SB, Wung WE, Taetle R, Hussain F, Romine JS. Modulation of 5-fluorouracil toxicity by allopurinol in man. Cancer 1981, 48:1281-1289.
6. Karthaus M, Rosenthal C, Huebner G, Paul H, ElSeries C, Hertenstein B, Krauter J, Scharmann T, Geissler RG, Heil G, GanSeries A. Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial. Bone Marrow Transplantation 1998, 22:781-785.
7. Loprinzi CL, Cianflone SG, Dose AM, Etzell PS, Burnham NL, Therneau TM, Hagen L, Gainey DK, Cross M, Athmann LM. A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis. Cancer 1990, 65:1879-1882.
8. Plevova P. Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review. Oral Oncology 1999, 35:453-470.
9. Porta C, Moron M, Nastasi G. Allopurinol mouthwashes in the treatment of 5-fluorouracil-induced stomatitis. American Journal of Clinical Oncology 1994, 17:246-247.
10. Potting CM, Uitterhoeve R, Op Reimer WS, Van Achterberg T. The effectiveness of commonly used mouthwashes for the prevention of chemotherapy-induced oral mucositis: a systematic review. European Journal of Cancer Care 2006, 15:431-439.
11. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004, 100(9):1995-2025. Suppl
12. Tartarone A, Matera R, Romano G, Vigliotti ML, Di Renzo N. Prevention of high-dose melphalan-induced mucositis by cryotherapy. Leukemia and Lymphoma 2005, 46:633-634.
13. Tsavaris N, Caragiauris P, Kosmidis P. Reduction of oral toxicity of 5-fluorouracil by allopurinol mouthwashes. European Journal of Surgical Oncology 1988, 14:405-406.
14. Tsavaris NB, Komitsopoulou P, Tzannou I, Loucatou P, Tsaroucha-Noutsou A, Kilafis G, Kosmidis P. Decreased oral toxicity with the local use of allopurinol in patients who received high dose 5-fluorouracil. Selective Cancer Therapeutics 1991, 7:113-117.
15. Wardley AM, Jayson GC, Swindell R, Morgenstern GR, Chang J, Bloor R, Fraser CJ, Scarffe JH. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. British Journal of Haematology 2000, 110:292-299.
16. Worthington HV, Clarkson JE, Eden OB. Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews 2006, 19:CD0001973.